Singapore markets open in 2 hours 30 minutes

Eupraxia Pharmaceuticals Inc. (EPRX.TO)

Toronto - Toronto Real-time price. Currency in CAD
Add to watchlist
4.1400+0.0900 (+2.22%)
At close: 02:41PM EDT
Currency in CAD

Valuation measures4

Market cap (intra-day) 85.57M
Enterprise value 65.89M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)4.21
Enterprise value/revenue N/A
Enterprise value/EBITDA -3.88

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3116.75%
S&P500 52-week change 3-13.21%
52-week high 35.2300
52-week low 30.8000
50-day moving average 34.2454
200-day moving average 32.8303

Share statistics

Avg vol (3-month) 328.69k
Avg vol (10-day) 34.28k
Shares outstanding 521.74M
Implied shares outstanding 6N/A
Float 8N/A
% held by insiders 112.35%
% held by institutions 120.16%
Shares short (14 Mar 2023) 4133.16k
Short ratio (14 Mar 2023) 45.23
Short % of float (14 Mar 2023) 41.56%
Short % of shares outstanding (14 Mar 2023) 40.62%
Shares short (prior month 14 Feb 2023) 4127.16k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Dec 2022


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
Net income avi to common (ttm)N/A
Diluted EPS (ttm)-1.0700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)N/A
Total cash per share (mrq)N/A
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)N/A
Book value per share (mrq)0.95

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A